FDA shuts down stem cell clinics

FDA Seeks Permanent Injunctions Against Two Stem Cell Clinics (ODT Mag)
The two clinics allegedly marketed products without FDA approval.
The U.S. Food and Drug Administration (FDA), in two complaints filed in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice (cGMP) requirements.
“Cell-based regenerative medicine holds significant medical opportunity, but we’ve also seen some bad actors leverage the scientific promise of this field to pedd...